1. Altinbas M, Coskun HS, Er O, Ozkan M, Eser B, Unal A, Cetin M, Soyuer S (2004) A randomized clinical trial of combination chemotherapy with and without low-molecular-weight heparin in small cell lung cancer. J Thromb Haemost 2:1266–1271
2. Dvorak HF, Rickles FR (2006) Malignancy and hemostasis. In: Colman RW, Marder VJ, George JN, Goldhaber SZ (eds) Hemostasis and thrombosis, basic principles and clinical practice, 5th edn. Lipincott, Williams & Wilkins, Philadelphia, pp 851–873
3. Levine MN, Lee AYY, Kakkar AK (2006) Cancer and thrombosis. In: Colman RW, Marder VJ, George JN, Goldhaber SZ (eds) Hemostasis and thrombosis, basic principles and clinical practice, 5th edn. Lipincott, Williams & Wilkins, Philadelphia, pp 1251–1262
4. Miller GJ, Bauer KA, Howarth DJ et al (2004) Increased incidence of neoplasia of the digestive track in men with persistent activation of the coagulation pathway. J Thromb Haemost 2:2107–2114
5. Norman PH, Thall PF, Purugganan RV, Riedel BJ, Thakar DR, Rice DC, Huynh L, Qiao W, Wen S, Smythe WR (2009) A possible association between aprotinin and improved survival after radical surgery for mesothelioma. Cancer 115:833–841